ACP
INSM icon

Acuta Capital Partners’s Insmed INSM Stock Holding History

Acuta Capital Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,878
Closed -$4.5M – 31
2025
Q4 		$4.5M Sell
25,878
-12,714
-33% -$2.32M 3.06% 9
2025
Q3 		$5.56M Buy
38,592
+1,522
+4% +$186K 5.74% 5
2025
Q2 		$3.73M Sell
37,070
-69,004
-65% -$5.28M 5.21% 7
2025
Q1 		$8.09M Buy
106,074
+1,274
+1% +$97.5K 9.38% 2
2024
Q4 		$7.24M Sell
104,800
-2,700
-3% -$194K 7.28% 2
2024
Q3 		$7.85M Buy
107,500
+35,400
+49% +$2.61M 6.36% 4
2024
Q2 		$4.83M Buy
72,100
+10,382
+17% +$403K 4.07% 10
2024
Q1 		$1.67M Buy
61,718
+32,218
+109% +$902K 1.09% 24
2023
Q4 		$914K Buy
+29,500
New +$765K 0.51% 32
2021
Q2 		– Sell
-42,500
Closed -$1.45M – 44
2021
Q1 		$1.45M Buy
+42,500
New +$1.62M 0.52% 39
2020
Q1 		– Sell
-169,000
Closed -$4.04M – 34
2019
Q4 		$4.04M Sell
169,000
-51,000
-23% -$1.04M 1% 25
2019
Q3 		$3.88M Sell
220,000
-215,500
-49% -$4.16M 2.8% 13
2019
Q2 		$11.1M Buy
435,500
+65,500
+18% +$1.82M 3.96% 11
2019
Q1 		$10.8M Buy
+370,000
New +$9.59M 5.11% 5
2016
Q3 		– Sell
-220,000
Closed -$2.17M – 71
2016
Q2 		$2.17M Buy
+220,000
New +$2.57M 1.04% 27
2015
Q2 		– Sell
-150,000
Closed -$3.12M – 55
2015
Q1 		$3.12M Buy
150,000
+136,846
+1,040% +$2.41M 2.63% 12
2014
Q4 		$203K Buy
+13,154
New +$187K 0.14% 61

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acuta Capital Partners's INSM Position: Q1 2026 in Review

Acuta Capital Partners sold out of Insmed (INSM) in Q1 2026, closing a stake of 25,878 shares — an estimated $4.5M sold.

Acuta Capital Partners first reported a position in INSM in Q4 2014 and held it in 17 quarters. The position peaked at $11.1M in Q2 2019. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Acuta Capital Partners reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Acuta Capital Partners sold 25,878 Insmed shares in Q1 2026, an estimated $4.5M.
  • Acuta Capital Partners first reported a position in Insmed in Q4 2014 and held it in 17 quarters.
  • Acuta Capital Partners's Insmed position peaked at $11.1M in Q2 2019.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Acuta Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.